| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |